GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Niva Bupa Health Insurance Company NIVABUPA.NS · INR

Financials · NSE · 🇮🇳 India

Compare

75.66

-0.55%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Niva Bupa Health Insurance Company

Its shares trade on NSE under the ticker NIVABUPA.NS. It has been listed since 14 November 2024. In the fiscal year to 31 March 2026, it reported revenue before interest expense of ₹66.95bn and net income of ₹1.31bn. At that date it held total assets of ₹112.76bn and shareholders' equity of ₹31.99bn.

Niva Bupa Health Insurance Company Ltd is a IN-based company operating in Insurance industry. The company is headquartered in Gurgaon, Haryana. The company went IPO on 2024-11-14. Niva Bupa Health Insurance Company Limited is an India-based standalone health insurer (SAHI), focused on the retail health market. The firm's products are categorized into retail products, which are intended for individuals and families, and group products, which are intended for employers and employees, as well as third parties such as customers of banks and other corporate agents. Its businesses include health insurance, personal accident and travel insurance. Its health insurance business includes both indemnity-based and benefit-based health insurance products which are offered to retail and group customers. Its personal accident business includes primarily benefit-based products offered to retail and group customers. Its travel insurance business includes a combination of indemnity-based and benefit-based products, along with travel inconvenience benefits. Its travel insurance products are offered to retail and group customers, including domestic and international travelers.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Financials
Industry
Insurance
Listed since
14 Nov 2024
Employees
7,868

Leadership

Pay as last reported

  • Mr. Krishnan RamachandranChief Executive Officer, Managing Director
  • Mr. Rajat SharmaCompany Secretary₹3.5m
  • Ms. Penelope DudleyDirector
  • Mr. David FletcherDirector
  • Mr. Maninder JunejaNominee Director
  • Mr. Chandrashekhar BhaveIndependent Director
  • Mr. Dinesh MittalIndependent Director
  • Mr. Mohit GuptaAdditional Non-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company operates as a standalone health insurer focused on the retail health market.
  • It offers a diverse range of products including health, personal accident, and travel insurance.
  • The company has a clear product categorization into retail and group segments for different customer types.

Weaknesses

  • The company is a relatively new entrant with an IPO scheduled for 2024-11-14.
  • The company's website is provided but no specific details about its digital platform capabilities are given.
  • The company's product offerings are described without specific market share or competitive advantage details.

Opportunities

  • The company can leverage its focus on the retail health market to expand its customer base.
  • The company can potentially grow its group products by partnering with employers and corporate agents.
  • The company can explore expanding its travel insurance offerings to include domestic and international markets.

Threats

  • The company faces competition from established players in the health insurance industry.
  • The company's IPO date is in the future, which may introduce market volatility and uncertainty.
  • The company's reliance on retail and group segments may expose it to economic downturns affecting consumer spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.